WASHINGTON, DC – House Energy and Commerce Committee leaders today unveiled draft legislation to repeal the current Sustainable Growth Rate (SGR) system and replace it with a fair and stable system of physician payment in the Medicare program. The draft legislation is the latest step in the transparent process to reform the system and reward providers for delivering high-quality, efficient health care.
Committee Continues Transparent Medicare Physician Payment Reform Process – Releases Draft Legislative FrameworkMay 28, 2013 | Press Release
WASHINGTON, DC – Communications and Technology Subcommittee Chairman Greg Walden (R-OR) will appear on C-SPAN’s Communicators program this weekend to discuss the panel’s upcoming agenda. Click here to watch online now or on C-SPAN on Saturday, May 25 at 6:30 p.m.
WASHINGTON, DC – House Energy and Commerce Committee leaders have expanded their examination into reports that Health and Human Services Secretary Kathleen Sebelius may have solicited funding or assistance from the health care industry to help implement the health care law.
Committee Launches Bipartisan Investigation into Department of Commerce Office of the Inspector GeneralMay 23, 2013 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI), Ranking Member Henry A. Waxman (D-CA), Oversight and Investigations Subcommittee Chairman Tim Murphy (R-PA), and Ranking Member Diana DeGette (D-CO) today wrote to the Government Accountability Office (GAO) requesting an examination of the performance, effectiveness, and management of the Office of Inspector General at the Department of Commerce (DOC-IG).
In Wake of Meningitis Investigation Findings, Health Panel Reviews Safety and Importance of Compounded DrugsMay 23, 2013 | Press Release
WASHINGTON, DC – The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today examined the current state of drug compounding in the United States. The hearing was a continuation of the committee’s investigation of the fungal meningitis outbreak, and whether the Food and Drug Administration (FDA) could have prevented the outbreak, which resulted from contaminated injections made by the New England Compounding Center (NECC).
Vitter, Upton Ask GAO to Examine Controversial Cost-Benefit Analysis Procedures at Nuclear Regulatory CommissionMay 23, 2013 | Press Release
WASHINGTON, DC – Senate Environment and Public Works Committee Ranking Member David Vitter (R-LA) and House Energy and Commerce Committee Chairman Fred Upton (R-MI) today sent a letter to Gene Dodaro, Comptroller General of the U.S. Government Accountability Office (GAO), asking for a report on the methods and procedures currently being utilized by the Nuclear Regulatory Commission (NRC) to conduct cost analyses when developing and proposing new policies and regulations.